Abbott Loses Drug Patent Suit with Centocor

Cited from NewYork Times. A unit of Johnson & Johnson said Monday that a jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over rheumatoid arthritis drugs.
Abbott’s best-selling drug, Humira, competes with the drug Remicade, an arthritis treatment made by the Centocor unit of Johnson & Johnson. That company and [...]

Australia – Innovation Patent

The Australia has a separate Patent protection apart from regular utility Patent termed “Innovation patent”, is a protection option specifically designed to protect inventions that do not meet the inventive threshold required for standard patents. Introduced in 2001 to stimulate innovation among small to medium business and local industry, the innovation patent is a relatively [...]